You are here

  • Home
  • Archive
  • Volume 59, Issue 4
  • Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey

Article Text

Article menu
Download PDFPDF
Respiratory epidemiology
Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey
  1. C Svanes1,2,
  2. E Omenaas1,
  3. D Jarvis3,
  4. S Chinn3,
  5. A Gulsvik1,
  6. P Burney3
  1. 1Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway
  2. 2Department of Medicine, Haraldsplass Hospital, Bergen, Norway
  3. 3Department of Public Health Sciences, King’s College London, London SE1 3QD, UK
  1. Correspondence to:
    Dr C Svanes
    Department of Medicine, Haraldsplass Hospital, 5009 Bergen, Norway; cecilie.svanesmed.uib.no

Abstract

Background: Early exposure to parental smoking appears to influence the development of the airways and predispose to respiratory symptoms. A study was undertaken to determine whether the consequences of parental smoking could be traced in adulthood.

Methods: Information from interviewer-led questionnaires was available for 18 922 subjects aged 20–44 years from random population samples in 37 areas participating in the European Community Respiratory Health Survey. Lung function data were available for 15 901 subjects.

Results: In men, father’s smoking in childhood was associated with more respiratory symptoms (ORwheeze 1.13 (95% CI 1.00 to 1.28); never smokers: ORwheeze 1.21 (95% CI 0.96 to 1.50)) and there was a dose-dependent association between number of parents smoking and wheeze (one: OR 1.08 (95% CI 0.94 to 1.24); both: OR 1.24 (95% CI 1.05 to 1.47); ptrend  =  0.010). A reduced ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) was related to father’s smoking (−0.3% (95% CI −0.6 to 0)) and number of parents smoking (ptrend <0.001) among men. In women, mother’s smoking was associated with more respiratory symptoms and poorer lung function (ORwheeze 1.15 (95% CI 1.01 to 1.31), never smokers: ORwheeze 1.21 (95% CI 0.98–1.51); FEV1 −24 ml (95% CI −45 to −3); FEV1/FVC ratio −0.6% (95% CI −0.9 to −0.3)). These effects were possibly accounted for by maternal smoking in pregnancy (ORwheeze 1.39 (95% CI 1.17 to 1.65); FEV1 −23 ml (95% CI −52 to 7); FEV1/FVC ratio −0.9% (95% CI −1.3 to −0.4)) as there was no association with paternal smoking among women (interaction by sex, p<0.05). These results were homogeneous across centres.

Conclusion: Both intrauterine and environmental exposure to parental tobacco smoking was related to more respiratory symptoms and poorer lung function in adulthood in this multicultural study. The age window of particular vulnerability appeared to differ by sex, postnatal exposure being important only in men and a role for prenatal exposure being more evident in women.

  • environmental tobacco smoke
  • smoking
  • parental smoking
  • maternal smoking in pregnancy
  • obstructive lung disease
  • BHR, bronchial responsiveness
  • ECRHS, European Community Respiratory Health Survey
  • ETS, environmental tobacco smoke
  • FEV1, forced expiratory volume in 1 second
  • FVC, forced vital capacity

https://doi.org/10.1136/thx.2003.009746

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Coordinating Centre (London): P Burney, S Chinn, C Luczynska, D Jarvis, E Lai.

    • Project Management Group: P Burney (Project leader), S Chinn, C Luczynska, D Jarvis, P Vermeire (Antwerp), H Kesteloot (Leuven), J Bousquet (Montpellier), D Nowak (Hamburg), the late J Prichard (Dublin), R de Marco (Verona), B Rijcken (Groningen), J M Anto (Barcelona), J Alves (Oporto), G Boman (Uppsala), N Nielsen (Copenhagen), P Paoletti (Pisa).

    • Participating Centres: Austria: W Popp (Vienna); Australia: M Abramson, J Raven, J Rolland (Melbourne); Belgium: P Vermeire, F van Bastelaer (Antwerp South, Antwerp Central); Denmark: M Iversen (Aarhus); Estonia: R Jögi (Tartu); France: J Bousquet J Knani (Montpellier) F Neukirch, R Liard (Paris), I Pin, C Pison (Grenoble), A Taytard (Bordeaux); Germany: H Magnussen, D Nowak (Hamburg), H E Wichmann, J Heinrich (Erfurt); Greece: N Papageorgiou, P Avarlis, M Gaga, C Marossis (Athens); Iceland: T Gislason, D Gislason (Reykjavik); Ireland: J Prichard, S Allwright, D MacLeod (Dublin); Italy: M Bugiani, C Bucca, C Romano (Turin), R de Marco Lo Cascio, C Campello (Verona), A Marinoni, I Cerveri, L Casali (Pavia); Netherlands: B Rijcken, A Kremer (Groningen, Bergen-op-Zoom, Geleen); New Zealand: J Crane, S Lewis (Wellington, Christchurch, Hawkes Bay); Norway: A Gulsvik, E Omenaas (Bergen); Portugal: J A Marques, J Alves (Oporto); Spain: J M Antó, J Sunyer, F Burgos, J Castellsagué, J Roca, J B Soriano, A Tobías (Barcelona), N Muniozguren, J Ramos González, A Capelastegui (Galdakao), J Castillo, J Rodriguez Portal (Seville), J Martinez-Moratalla, E Almar (Albacete), J Maldonado Pérez, A Pereira, J Sánchez (Huelva), J Quiros, I Huerta, F Pavo (Oviedo); Sweden: G Boman, C Janson, E Björnsson (Uppsala), L Rosenhall, E Norrman, B Lundbäck (Umeå), N Lindholm, P Plaschke (Göteborg); Switzerland: U Ackermann-Liebrich, N Künzli, A Perruchoud (Basel); United Kingdom: M Burr, J Layzell (Caerphilly), R Hall (Ipswich), B Harrison (Norwich), J Stark (Cambridge); USA: S Buist, W Vollmer, M Osborne (Portland).

    Linked Articles

    • airwaves
      Airwaves
      Wisia Wedzicha
      Thorax 2004; 59 273-273 Published Online First: 26 Mar 2004.